 Lille France, Cambridge Massachusetts, United States, November 23, 2020 GENFIT Nasdaq and Euronext: GNFT a late-stage biopharmaceutical company dedicated to improving the lives of patients with metabolic and chronic liver diseases, today announced the final terms of the partial buyback of its convertible bonds maturing in October 2022 2022 OCEANEs or OCEANEs and the proposed amendment of the existing terms of the 2022 OCEANEs. 